The Expanding Role Of Medical Affairs
Executive Summary
Medical affairs organizations support a range of post-launch activities.
You may also be interested in...
Achieving Medical Affairs Excellence In China
As the second largest biopharmaceutical market, China presents tremendous opportunity, but companies will need to mature medical affairs teams quickly as the market continues to evolve. To strengthen their medical affairs teams, pharmaceutical companies will need to be creative with their physician and stakeholder engagement models, as well as cultivating the local talent.
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Need a specific report? 1000+ reports available
Buy Reports